Malarone is not an antibiotic. It is an antimalarial medication, meaning it specifically targets the parasites that cause malaria rather than bacteria. The FDA classifies both of its active ingredients, atovaquone and proguanil, as antimalarial agents. This is a common point of confusion because one of the other drugs used to prevent malaria, doxycycline, actually is an antibiotic, and the two are often discussed side by side.
Why People Confuse Malarone With an Antibiotic
If you’re preparing for travel to a malaria-risk area, your doctor might offer you a choice between Malarone and doxycycline. Doxycycline is a true antibiotic. It kills bacteria and is commonly prescribed for acne, respiratory infections, and tick-borne illnesses. It also happens to work against malaria parasites, which is why it pulls double duty as a malaria prevention drug. The CDC notes that doxycycline can also protect against some additional infections like Rickettsia and leptospirosis, making it a popular choice for travelers doing a lot of hiking, camping, or freshwater swimming.
Malarone, by contrast, has no meaningful antibacterial activity. It works exclusively against the Plasmodium parasites responsible for malaria. So while both drugs end up in the same conversation at a travel clinic, they belong to entirely different drug classes.
How Malarone Actually Works
Malaria is caused by single-celled parasites, not bacteria. The parasites enter your bloodstream through a mosquito bite, travel to your liver, and then infect red blood cells. Malarone disrupts this process by attacking the parasite’s ability to reproduce.
Its two ingredients hit the parasite from two different angles. Atovaquone shuts down energy production inside the parasite’s cells by blocking a critical step in its energy-generating machinery. Proguanil interferes with the parasite’s ability to build new DNA. Together, they cut off both the energy supply and the replication process, which is why the combination is so effective and why resistance to Malarone remains rare even after decades of use. Research published in Nature Communications confirmed that field resistance to atovaquone has not become established, and the handful of documented treatment failures involve specific genetic mutations in the parasite that appear to compromise the parasite’s own ability to spread through mosquitoes.
What Malarone Is Used For
Malarone serves two purposes: preventing malaria in travelers and treating active malaria infections. For prevention, you start taking it one to two days before entering a malaria zone, continue daily while there, and keep taking it for seven days after you leave. This is a shorter tail than doxycycline, which requires four weeks of continued dosing after departure.
For treating an active, uncomplicated malaria infection, the standard adult course is four tablets once daily for three days. Pediatric doses are weight-based, with children as small as 5 kilograms eligible for treatment using smaller-dose pediatric tablets. The drug should be taken with food to improve absorption.
Side Effects
Malarone is considered one of the better-tolerated antimalarials. When used for prevention, side effects in clinical trials occurred at roughly the same rate as placebo. The most common complaints were headache (reported by about 7% of adults) and abdominal pain (5%), both of which also showed up at similar rates in people taking a sugar pill.
Side effects are more noticeable when Malarone is used at the higher treatment dose. In adults treated for active malaria, the most frequent issues were abdominal pain (17%), nausea (12%), vomiting (12%), headache (10%), diarrhea (8%), weakness (8%), loss of appetite (5%), and dizziness (5%). Children tolerated treatment better overall, with vomiting (10%) and itching (6%) being the main complaints in kids weighing 11 to 40 kilograms.
Because Malarone is not an antibiotic, it does not carry the antibiotic-related side effects that come with doxycycline, such as increased sun sensitivity, disruption of gut bacteria, or vaginal yeast infections. The CDC specifically notes that women prone to yeast infections while on antibiotics may prefer a non-antibiotic option for malaria prevention.
Who Should Not Take Malarone
Malarone is not recommended during pregnancy or for infants weighing less than 5 kilograms. Women who are breastfeeding infants under that weight threshold should also avoid it. People with severe kidney impairment cannot use Malarone because the drug is cleared through the kidneys. If you’ve already been taking Malarone for prevention and develop malaria anyway, a different antimalarial should be used for treatment rather than increasing the Malarone dose.